Lyell Immunopharma Inc (LYEL)
NASDAQ NMS - GLOBAL MARKET · Biotechnology
$12.99+0.03 (+0.23%)Quote refreshed
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
$318.3M
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
No company overview is available for Lyell Immunopharma Inc yet.
Peers in Biotechnology
All in industry →VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%
Recent press releases
Lyell Immunopharma Inc has not issued a press release in this window.
SEC filings
All filings →Lyell Immunopharma Inc has not filed an SEC document in this window.
Insider trades
All insider trades →Lyell Immunopharma Inc has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
Decheng Capital LLC$21.3M
692,050 sh+16.2%
People at Lyell Immunopharma Inc
All people →Quarterly financials
Full financials →Revenue trend
03/25
$7.0K
NI -$52.2M
06/25
$8.0K
NI -$42.7M
09/25
$15.0K
NI -$38.8M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-2.13
Prior: $-2.89
Revenue sparkline